BioXcel Therapeutics, Inc. (BTAI) Operating cash flow 2017–2025
BioXcel Therapeutics, Inc. (BTAI) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$57.6MFY2025 · since FY2017: -$2.2M → -$57.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$57.6M | +20.0% |
| FY2024 | -$72.0M | +53.5% |
| FY2023 | -$155.0M | -14.5% |
| FY2022 | -$135.3M | -64.7% |
| FY2021 | -$82.2M | -23.8% |
| FY2020 | -$66.3M | -144.8% |
| FY2019 | -$27.1M | -100.6% |
| FY2018 | -$13.5M | -515.2% |
| FY2017 | -$2.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice